Saakshi Medtech & Panels Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Electrical Equipment | Market Cap: ₹521 Cr
The company targets revenue of around Rs. The company expects approximately 15% revenue growth in H2 FY'26 compared to H1 FY'26. - For FY'27 and beyond, growth drivers include aerospace and radiator businesses expected to significantly boost revenues. - Aerospace segment is anticipated to contribute around 20% of revenue within the next couple of years with better-than-20% EBITDA margins. - Radiator business margins are expected around 20% once scaled. - EBITDA margins improved to around 18.7% in H1 FY'26 and are expected to sustain at similar levels in the near term. - Operating leverage and new high-margin segments (aerospace, radiators) are key margin expansion drivers. - No exact EPS guidance or numeric profit forecasts were provided, but stable margin trends with ongoing revenue growth are projected. - The potential revenue target from current assets gross block (~Rs.
From Saakshi Medtech & Panels Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Price
₹289
Market Cap
₹521 Cr
P/E Ratio
42.4
Revenue Rank
Margin Rank
How does Saakshi Medtech & Panels Ltd rank in Electrical Equipment?
Compare Saakshi Medtech & Panels Ltd against every Electrical Equipment company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
Rank 3- →The company targets revenue of around Rs. 140 crores for the current financial year FY'26, with H2 expected to outperform H1 by roughly 15%.
- →Significant growth drivers include aerospace and EV business segments, showing strong momentum and new opportunities.
- →The aerospace segment has seen nearly a 7-fold growth in H1 FY'26 compared to H1 FY'25 and is expected to contribute up to 20% of revenue within a couple of years.
- →Radiator business is set to contribute significantly starting FY'27, supported by a new facility and early customer interest.
- →Order book visibility is typically quarterly; currently, about Rs. 50 crores of orders for the ongoing quarter, with defense orders being a small portion (~5%).
- →Further growth is anticipated from value-added processes and new customer acquisitions, particularly in aerospace and radiator segments.
- →Overall, medium-term growth is expected to be robust, driven by expanded certifications, new product qualifications, and market expansion.
📈 Profitability & Margins
Rank 3- →The company expects approximately 15% revenue growth in H2 FY'26 compared to H1 FY'26.
- →For FY'27 and beyond, growth drivers include aerospace and radiator businesses expected to significantly boost revenues.
- →Aerospace segment is anticipated to contribute around 20% of revenue within the next couple of years with better-than-20% EBITDA margins.
- →Radiator business margins are expected around 20% once scaled.
- →EBITDA margins improved to around 18.7% in H1 FY'26 and are expected to sustain at similar levels in the near term.
- →Operating leverage and new high-margin segments (aerospace, radiators) are key margin expansion drivers.
- →No exact EPS guidance or numeric profit forecasts were provided, but stable margin trends with ongoing revenue growth are projected.
- →The potential revenue target from current assets gross block (~Rs. 147 crores) could be around Rs. 500 crores, implying a 3x asset turnover long term.
🏗️ Capital Expenditure Plans
Yes💰 Fundraising & Capital Structure
No- →No significant new CAPEX is planned going forward; only around Rs. 5 crores anticipated for completion of the new facility.
- →The company does not intend to raise additional debt; any future investment will be funded through internal cash flows.
- →Current increase in long-term borrowings was due to term loans utilized for constructing the first floor of a newly acquired facility.
- →No plans for equity fundraising or employee stock options as per current disclosures.
- →The management emphasizes prudent financial discipline with focus on organic growth and operational efficiency rather than external fundraising.
📋 Order Book & Pipeline
Yes- →Current quarter order book stands at approximately Rs. 50 crores.
- →Defense portion forms about 5% of the current order book.
- →The Mahindra EV Panel's 5-year order remains intact with ongoing execution; Rs. 10 crores executed from Feb '24 to Sept '25, with around Rs. 230 crores pending over the next 4 years.
- →The company typically has rolling quarterly visibility on orders rather than a long-term order book.
- →Discussions and activities are ongoing with customers like Siemens and GE Vernova; however, order flows from these are expected only in the next 6 months or later.
- →Order inflows depend on quarterly contract renewals with most OEMs.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Saakshi Medtech & Panels Ltd Q2 FY26 results?
The company targets revenue of around Rs. The company expects approximately 15% revenue growth in H2 FY'26 compared to H1 FY'26. - For FY'27 and beyond, growth drivers include aerospace and radiator businesses expected to significantly boost revenues. - Aerospace segment is anticipated to contribute around 20% of revenue within the next couple of years with better-than-20% EBITDA margins. - Radiator business margins are expected around 20% once scaled. - EBITDA margins improved to around 18.7% in H1 FY'26 and are expected to sustain at similar levels in the near term. - Operating leverage and new high-margin segments (aerospace, radiators) are key margin expansion drivers. - No exact EPS guidance or numeric profit forecasts were provided, but stable margin trends with ongoing revenue growth are projected. - The potential revenue target from current assets gross block (~Rs.
What is Saakshi Medtech & Panels Ltd share price analysis?
Saakshi Medtech & Panels Ltd currently shows a below-average growth signal. The stock trades at a P/E of 42.4 with a market cap of ₹521 Cr. Investors should review the full earnings analysis for detailed insights.
Is Saakshi Medtech & Panels Ltd planning capital expenditure?
Current CAPEX includes ongoing infrastructure build-out with Rs.
Keep Saakshi Medtech & Panels Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
